NRX Pharmaceuticals, Inc. current report, 07 February 2020

Business Context and Reporting Period

This Form 8-K is a current report filed by Big Rock Partners Acquisition Corp. (not NRX Pharmaceuticals, Inc., as indicated in the metadata) on February 7, 2020. The registrant is a Delaware corporation and an emerging growth company. Its securities, including Units, Common Stock, Rights, and Warrants, trade on The NASDAQ Stock Market LLC under the symbols BRPAU, BRPA, BRPAR, and BRPAW, respectively.

Key Financial Metrics

The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.

Material Changes

The primary material change reported is the departure of a director and officer and the subsequent appointment of a replacement:

  • Resignation: Lori B. Wittman resigned as a Director and Chief Financial Officer (CFO) effective February 7, 2020. The filing states her resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
  • Appointment: On the same date, the Board appointed Bennett Kim to fill the vacancy on the Board and as the new Chief Financial Officer.

Management Commentary and Background

The filing provides a detailed professional background for the newly appointed CFO, Bennett Kim:

  • Current Roles: Served as Chief Investment Officer and Corporate Secretary since September 18, 2017, and Managing Principal of Big Rock Senior Housing since January 2016.
  • Prior Experience: Former Chief Investment Officer at Big Rock Partners (2006–2014), Head of Acquisitions at Carefree Communities (2014–2015), and Vice President at Apollo (2001–2006).
  • Education: Holds an M.B.A. from Harvard Business School and a B.A. in Economics from UCLA.

The filing contains no guidance, outlook, or discussion of risks, contingencies, or unusual items beyond the personnel changes.

Investor Verification Checklist

  • Verify the correct registrant name is Big Rock Partners Acquisition Corp., not NRX Pharmaceuticals, Inc.
  • Confirm the effective date of Bennett Kim's appointment as CFO and Director (February 7, 2020).
  • Review the trading symbols (BRPAU, BRPA, BRPAR, BRPAW) to ensure accurate identification of the company's securities on NASDAQ.
  • Note that no financial performance data is included in this specific filing.